Overview

Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS

Status:
Recruiting
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
This study aimed to evaluate the safety and efficacy of unrelated umbilical cord blood microtransplantation in the treatment of above-mentioned MDS patients by observing the factors related to the efficacy and adverse reactions.
Phase:
Phase 2
Details
Lead Sponsor:
Anhui Provincial Hospital
Treatments:
Azacitidine
Venetoclax